Skip to content

Transcranial photobiomodulation

Head-targeted light is being studied for specific cognitive outcomes; wavelengths, placement and research populations shape what the findings mean.

Recovery & physical modalitiesdeviceEmerging

Label covers Specified cognitive-test outcomes; not general helmet efficacy

Availability At home

What it is

Transcranial photobiomodulation directs light at the head with the aim of influencing brain activity. Devices include headsets and targeted light applicators. This is a different use from illuminating skin or muscles, even when both treatments use near-infrared light.

Why people use it

The intended benefits include clearer thinking and better performance on memory tasks. Those are wellspan goals in healthy people. Research involving cognitive impairment addresses a healthspan concern, but a better test score doesn't itself demonstrate prevention of dementia.

How it's delivered

Treatment depends on wavelength, placement, light output and exposure schedule. A helmet illuminating several areas differs from a laser aimed at one site. A commercially available headset therefore needs its own evidence rather than borrowing results from a different device or patient group. The intended outcome should be clear before someone begins a course.

Where the evidence stands

The Emerging grade describes specific cognitive outcomes in controlled studies. A home-treatment trial in people with mild cognitive impairment related to Alzheimer's disease improved cognitive scores over a short follow-up. Other populations have produced different findings, including a concussion trial that did not show benefit over placebo. These results don't establish lasting disease modification or a benefit from every helmet. The cognitive-impairment trial describes its particular treatment.

Estimated cost

One head-light device was listed at US $3,395 excluding sales tax on September 15, 2026. That example establishes an asking price, not that the device matches the clinical trial.

Who offers it

Neuronic lists the Neuradiant 1070 for sale. Its wavelength differs from the treatment used in the cited cognitive-impairment trial, so the trial isn't evidence for that product.

Longevity.io is for educational purposes only and is not medical advice. Provider listings and displayed prices were observed on September 15, 2026; final availability and charges require confirmation. We may be compensated when you contact providers through Longevity.io; payment never affects ranking. Device-specific eye and skin precautions require review before use. New memory problems deserve clinical assessment, and a light device should not replace established care. Short trials do not establish long-term safety.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint